Today we’re announcing our intent to separate our Orthopaedics business. We’re confident this move would further strengthen the focus of Johnson & Johnson on our six key growth areas – Oncology, Immunology, Neuroscience, Cardiovascular, Surgery, and Vision. It would also establish a standalone Orthopaedics business, operating as Depuy Synthes, that would be the largest, most comprehensive orthopaedics-focused company with leading market share positions across major product categories.

Learn more: https://social.jnj.com/3KPCOob